Equinvest, SL
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Equinvest, SL - overview
Established
1991
Location
Madrid, -, Spain
Primary Industry
Pharmaceuticals
About
Based in Madrid, Spain, and founded in 1991, Equinvest, SL offers an online marketplace that sells veterinary care products. In April 2024, the firm raised venture funding led by Nzyme, a Private Equity fund of Kibo Ventures and Oliver Wyman. The firm as of May 2024, has more than 11,000 clients in Spain and Portugal with physical stores in Aravaca and Madrid, and is led by its CEO, Javier Póveda. The veterinary distributor specializes in equine health products, primarily focusing on the sale of supplements and veterinary items for horses.
The range of animal health and pharmacological products offered by Equinvest includes horse supplements like Iberolac a foal formula substitute for mare's milk for orphan foals, Hepatriation a supplement for normal liver functioning, etc, and hardware like HG600 Hay Steamer for eliminating up to 99% of the dust, bacteria, fungi, and mold that are found in hay. Additionally, the company also offers fungible, veterinary instruments, insecticides, antiseptics, disinfectants, horse wounds, horse care, clinical material, other animal species, equine breeding and reproduction, leather care, and feeding products. Equinvest generates revenue by selling its horse care products and supplements through its e-commerce website. Some examples include Bioactive 3X60GR at EUR 42.
29, Maxitop Equine 5KG at EUR 165. 06, Mondial Nails E4 500UD at EUR 24. 93, etc.
Current Investors
Kibo Ventures
Primary Industry
Pharmaceuticals
Sub Industries
Consumer Products, Pharmaceutical Research & Development
Website
www.equinvest.es
Verticals
E-commerce
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Equinvest, SL - financials
| Fiscal Year Ended | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 2,457,270.4 | 2,830,268.3 | 3,135,000.3 | 3,221,394.5 | 3,293,561.1 | 3,407,737.6 | 3,447,015.6 | 3,418,162.1 | 3,985,367.2 | - | - | - |
| % Revenue Growth (YoY) | - | 15.2% | 10.8% | 2.8% | 2.2% | 3.5% | 1.2% | (0.8%) | 16.6% | - | - | - |
| EBITDA (USD) | (58,715.1) | (70,211.3) | 65,189.3 | 144,922.2 | 133,791.2 | 150,793.9 | 88,168 | 421,218.8 | 423,148.7 | - | - | - |
| Operating Income (USD) | (61,611.8) | (72,862.8) | 57,701.7 | 136,882.5 | 126,087.7 | 139,654.8 | 76,276.5 | 410,773 | 398,432.9 | - | - | - |
| Operating Margin | (2.5%) | (2.6%) | 1.8% | 4.2% | 3.8% | 4.1% | 2.2% | 12.0% | 10.0% | - | - | - |
| % EBITDA Margin | (2.4%) | (2.5%) | 2.1% | 4.5% | 4.1% | 4.4% | 2.6% | 12.3% | 10.6% | - | - | - |
| NET Income (USD) | (46,208.9) | (54,669.6) | 42,746 | 130,434.4 | 93,948.7 | 106,870.2 | 59,135.2 | 305,965.6 | 398,169.6 | - | - | - |
| % Net Margin | (1.9%) | (1.9%) | 1.4% | 4.0% | 2.9% | 3.1% | 1.7% | 9.0% | 10.0% | - | - | - |
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.